Drug Farm

Drug Farm is a biotechnology company developing novel drug targets. From its funding announcement.

$55M Series D (first close)Raised 2 months agoNYC- and Shanghai, USABiotech & PharmaUSA
Visit website →

In their own words

What Drug Farm says it is doing

Work here? Claim your company profile

Public signal Described in the funding announcement as "biotechnology company developing novel drug targets". Source

Market expansionResearch and developmentRegulatory

Public signal Read from the company's own description of what the funding supports.

Why now

Where Drug Farm is today

Drug Farm announced a Series D round of $55M on 14 July 2026.

Latest round
Series D
Amount
$55M
Announced
14 July 2026
Headquarters
NYC- and Shanghai, USA
Sector
Biotech & Pharma
Growth stage
Series C+
Investors
Not stated
Also participating
Tukar Capital, Fuzhou Xinhe Fund, Shenzhen Luohu Donghai Chempartner Investment Fund, Keyuan Pharma
Relevant leadership
CEO Dr. Henri Lichenstein and COO Dr. Tony Xu

Momentum AfterRaise intelligence

AfterRaise Score

67
Building momentum
1 funding signal in the last 90 days
Funding recency
28/40
announced within the last 90 days
Round scale
19/25
round size relative to the market
Funding stage
20/20
Series D
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Since the raise

What has happened since

  • 14 July 2026
    $55M Series D
    Investors not stated in the announcement.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What may happen next

What this raise could create

AfterRaise intelligenceNot a statement of fact

What may happen next

  • New market entry
  • First local hires in the new market
  • Local entity and legal setup
  • Research programme expansion

Opportunities this could create

  • Clinical operations
  • Regulatory affairs
  • Quality systems
  • Scientific hiring
  • Licensing and BD partnerships

Based on the Biotech & Pharma sector, a Series C+ round and the priorities the company itself set out. Not a statement of fact.

Medium momentum4 connected signals
  • 14 July 2026$55M Series D announced
  • 14 July 2026Stated priority: market expansion
  • 14 July 2026Stated priority: research and development
  • 14 July 2026Stated priority: regulatory

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What Drug Farm is open to

Not yet specified

Drug Farm has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Opportunities

Ways to work with Drug Farm

No open opportunities listed

Jobs, projects, partnerships, advisory and supplier needs appear here once the company has claimed its page and published them, and any role we read from its own job board appears automatically.

Work here? Open the first one

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Do you work at Drug Farm?

Claim your company profile.

This page was created from publicly available information. A verified representative corrects the record, says what the company is building next and chooses which conversations it welcomes.

What we do not have yet: the roles and projects you have open. Claiming the page is how you fill those in.

Someone else requesting access does not give them ownership. Every representative is verified by a person before access is granted.

Maintaining your own company profile is free. A founder, CEO or authorised senior colleague can represent the company.

Also moving

Other Biotech & Pharma companies

See the sector